These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2584312)

  • 1. Comparison between two methods for the determination of the total and free (R)- and (S)-disopyramide in plasma using an alpha 1-acid glycoprotein column.
    Enquist M; Hermansson J
    J Chromatogr; 1989 Sep; 494():143-56. PubMed ID: 2584312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of (R)- and (S)-disopyramide in human plasma using a chiral alpha 1-acid glycoprotein column.
    Hermansson J; Eriksson M; Nyquist O
    J Chromatogr; 1984 Dec; 336(2):321-8. PubMed ID: 6530464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simultaneous determination of disopyramide and its mono-N-dealkylated metabolite enantiomers in human plasma and urine by enantioselective high-performance liquid chromatography.
    Takahashi H; Tamura A; Ogata H; Masuhara K
    J Chromatogr; 1990 Aug; 529(2):347-58. PubMed ID: 2229254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enantioselective analysis of disopyramide and mono-N-dealkyldisopyramide in plasma and urine by high-performance liquid chromatography on an amylose-derived chiral stationary phase.
    Bortocan R; Lanchote VL; Cesarino EJ; Bonato PS
    J Chromatogr B Biomed Sci Appl; 2000 Jul; 744(2):299-306. PubMed ID: 10993518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct enantiomeric resolution of disopyramide and its metabolite using chiral high-performance liquid chromatography. Application to stereoselective metabolism and pharmacokinetics of racemic disopyramide in man.
    Le Corre P; Gibassier D; Sado P; Le Verge R
    J Chromatogr; 1988 Oct; 450(2):211-6. PubMed ID: 3235589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stereoselective metabolism and pharmacokinetics of disopyramide enantiomers in humans.
    Le Corre P; Gibassier D; Sado P; Le Verge R
    Drug Metab Dispos; 1988; 16(6):858-64. PubMed ID: 2907466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of free disopyramide plasma concentrations using ultrafiltration and enzyme multiplied immunoassay.
    Raghow G; Meyer MC; Straughn AB
    Ther Drug Monit; 1985; 7(4):466-71. PubMed ID: 3909539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enantioselective binding of disopyramide to alpha1-acid glycoprotein and its variants.
    Kishino S; Itoh S; Nakagawa T; Miyazaki K
    Eur J Clin Pharmacol; 2001 Oct; 57(8):583-7. PubMed ID: 11758636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Separation and quantitation of (R)- and (S)-atenolol in human plasma and urine using an alpha 1-AGP column.
    Enquist M; Hermansson J
    Chirality; 1989; 1(3):209-15. PubMed ID: 2642050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stereoselective disposition and metabolism of disopyramide in pediatric patients.
    Echizen H; Takahashi H; Nakamura H; Ochiai K; Chiba K; Koike K; Ogata H; Ishizaki T
    J Pharmacol Exp Ther; 1991 Dec; 259(3):953-60. PubMed ID: 1762088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous determination of disopyramide and mono-N-dealkyldisopyramide enantiomers in plasma and urine by use of a chiral cellulose-derivative column.
    Echizen H; Ochiai K; Kato Y; Chiba K; Ishizaki T
    Clin Chem; 1990 Jul; 36(7):1300-4. PubMed ID: 2372941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between alpha 1-acid glycoprotein and distribution of disopyramide and mono-N-dealkyldisopyramide in whole blood.
    Bredesen JE; Kierulf P
    Br J Clin Pharmacol; 1986 Sep; 22(3):281-6. PubMed ID: 3768240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-pressure liquid chromatographic analysis of drugs in biological fluids. III. Analysis of disopyramide and its mono-N-dealkylated metabolite in plasma and urine.
    Meffin PJ; Harpat SR; Harrison DC
    J Chromatogr; 1977 Feb; 132(3):503-10. PubMed ID: 885947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disopyramide protein binding in plasma from patients with nephrotic syndrome during the exacerbation and remission phases.
    Echizen H; Saima S; Ishizaki T
    Br J Clin Pharmacol; 1987 Aug; 24(2):199-206. PubMed ID: 3620294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Automated determination of disopyramide and N-monodealkyldisopyramide in plasma by reversed-phase liquid chromatography with a column switching system.
    Del Cont Bernard A; Royer Morrot MJ; Zhiri A; Rambourg M; Royer RJ
    J Chromatogr; 1992 Feb; 574(2):365-8. PubMed ID: 1618974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disopyramide analysis using REMEDi: comparison with EMIT and conventional high performance liquid chromatographic methods.
    Patel V; McCarthy PT; Flanagan RJ
    Biomed Chromatogr; 1991 Nov; 5(6):269-72. PubMed ID: 1760593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma protein binding of disopyramide by equilibrium dialysis and ultrafiltration.
    David BM; Tjokrosetio R; Ilett KF
    Ther Drug Monit; 1983; 5(1):81-6. PubMed ID: 6845403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of electrocardiographic response and disposition of R- and S-disopyramide in the rabbit.
    Huang JD; Oie S
    Res Commun Chem Pathol Pharmacol; 1983 Aug; 41(2):227-41. PubMed ID: 6635318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of unbound fraction of disopyramide in plasma: a comparison of equilibrium dialysis, ultrafiltration through dialysis membranes and ultrafree anticonvulsant drug filters.
    Norris RL; Ahokas JT; Ravenscroft PJ
    J Pharmacol Methods; 1982 Jan; 7(1):7-14. PubMed ID: 7070107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid sample preparation and high performance liquid chromatographic determination of total and unbound serum disopyramide.
    Taylor EH; Nelson D; Taylor RD; Pappas AA
    Ther Drug Monit; 1986; 8(2):219-22. PubMed ID: 3726939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.